Xeraya Capital

Xeraya Capital

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Malaysia, Kuala Lumpur


This investor is located in Asia, Malaysia. The primary office of this VC is located in Kuala Lumpur.

The fund usually invests in rounds together with 4-5 others. Aside from Xeraya Capital, start-ups are often funded by OrbiMed, Khosla Ventures, Connecticut Innovations and 13 other funds. The most common co-investors for the fund are OrbiMed, OUP (Osage University Partners), Kearny Venture Partners and also 4 different VCs. In subsequent rounds, the fund is usually supported by OrbiMed, Kearny Venture Partners, Deerfield Capital Management.

Deals in the range of 10 - 50 millions dollars are most common for this fund. The fund generally invests in less than 2 deals every year. Xeraya Capital participates, on average, in 2 percentage points more than the average amount of lead investments in other funds. In real terms, this VC performs 26 percentage points more exits than other funds. The most exits for the fund occurred in 2018. The fund's activity peaked in 2016. In addition, the fund was active in 2019.

The overall number of key employee in the fund's team is 1.

The fund has no a preferred number of founders for start-ups that it invests in. ViewRay, Acutus Medical, Rapid Micro Biosystems are among the most popular portfolio start-ups of the fund. Among the most popular investment industries for the fund are Health Diagnostics, Therapeutics. However, the fund’s focus is not limited to this, since there are 8 more areas of investment. The country of its establishment and the country of its most frequent investments doesn't coincide - United States. However, start-ups from 1 other country can be found in the fund's portfolio. The average start-up age at the time of investment by this fund is 6-10.

Fund Activity


Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: xeraya.com; User name format in descending order of probability: first '.' last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

7.7% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]


Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

0.2 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.1 out of 1

Funds Investing in Previous

OrbiMed, Khosla Ventures, Connecticut Innovations

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: